Propel Bio Partners
Los Angeles, Californiapropelbio.com
Overview
Propel Bio Partners is a venture capital and equity investment firm that invests in and supports life science companies at various stages. The firm focuses on companies developing disruptive therapies and technologies to advance human health, with a portfolio spanning private and public biotech and pharma companies from clinical development to commercialization. Co-founded by Richard Kayne and Dr. Leen Kawas, the firm also emphasizes investing in companies that promote diversity and inclusive research.
Portfolio Companies
2
Website
propelbio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Inherent Biosciences, Inc. | Sep 2022 | Series A | Lead |
| Persephone Biosciences | Jul 2022 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
